A Study of KC1036 in Patients with Advanced Thymic Tumors
Clinical trial NCT05683886 · RECRUITING
Trial details
- NCT number
- NCT05683886
- Sponsor
- Beijing Konruns Pharmaceutical Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-22
- Primary completion
- 2025-02-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.